When we think about cell and gene therapy, blood banking or biopharmaceutical manufacturing, the spotlight usually goes to advanced drugs, automated equipment and breakthrough therapies. But there is a much simpler product quietly supporting these processes: cryopreservation and freezing bags.
These specialized bags are designed to safely store blood, cells, tissues and biological materials at extremely low temperatures, including cryogenic conditions approaching -196°C. Their importance is growing as more biological products move through research, clinical development and commercial manufacturing.
The numbers show why this niche is interesting
According to Towards Healthcare’s cryopreservation bags and freezing bags research, the global sector was valued at $162.06 million in 2025 and is estimated to reach $175.09 million in 2026. By 2035, it is projected to approach $351.17 million, representing an 8.04% CAGR.
| Indicator | Data |
|---|---|
| 2025 value | $162.06M |
| 2026 estimate | $175.09M |
| 2035 projection | $351.17M |
| 2026–2035 CAGR | 8.04% |
| North America share, 2025 | 38% |
| APAC growth outlook | 9.30% CAGR |
North America currently leads, while Asia Pacific is expected to grow faster. That makes the region particularly interesting for companies building biopharmaceutical and cell-therapy manufacturing capacity.
Big companies are already investing around this ecosystem
This is not an isolated consumables business. It sits inside a much larger bioprocessing ecosystem.
Thermo Fisher Scientific generated $44.56 billion in 2025 revenue, including $25.97 billion in product revenue. The company also spent approximately $1.40 billion on R&D in 2025.
Danaher, whose portfolio includes major life-science and bioprocess businesses, reported $24.57 billion in 2025 sales. Its Biotechnology segment generated $7.29 billion, while the company invested about $1.6 billion in R&D and $1.2 billion in capital expenditures.
Then there is Sartorius, a major bioprocess technology supplier. It reported €3.54 billion in 2025 sales, up 7.6% in constant currencies. More importantly, Sartorius invested €441.9 million in research and production infrastructure during 2025.
These numbers matter because growth in bioprocessing, cell therapy and sterile consumables creates demand for supporting products such as freezing and cryopreservation bags.
We analyze your business, understand your challenges, and provide solutions built around your growth goals. Download customized sample now: https://www.towardshealthcare.com/download-sample/5675
Where could the opportunity be in 2027?
For 2027, the interesting opportunity may not simply be selling standard bags. The stronger opportunity could be higher-value, validated and application-specific products.
Companies developing bags for cell and gene therapy, biologics, blood components and automated manufacturing workflows could benefit as manufacturing becomes more standardized.
Asia Pacific also deserves attention. Towards Healthcare expects APAC to be the fastest-growing regional area, with a projected 9.30% CAGR, creating potential opportunities for local manufacturing, sterile consumables and regional supply chains.
For investors, the broader theme is therefore more compelling than the bag itself: the expansion of biopharmaceutical manufacturing creates recurring demand for specialized consumables.
In 2027, companies combining cryogenic storage products with single-use bioprocessing, cell therapy manufacturing and sterile fluid-management technologies could be worth watching closely.
Important Links
Get a dashboard built around your niche; with the exact data and insights you need. Email: us at [email protected]
About Us
Healthcare WebWire is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium